- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Sporanox ( Itraconazole )
Sporanox (itraconazole) is a synthetic triazole antifungal agent indicated for the treatment of systemic fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and onychomycosis (fungal nail infection). It works by inhibiting the fungal cytochrome P450 enzyme lanosterol 14α-demethylase, which is essential for the synthesis of ergosterol, a key component of the fungal cell membrane. Depletion of ergosterol leads to increased membrane permeability, leakage of cellular contents, and ultimately fungal cell death. Itraconazole is available as capsules and oral solution; the capsule formulation requires gastric acidity for optimal absorption and is therefore used for systemic and nail infections, while the oral solution is used for oropharyngeal and esophageal candidiasis.
Usual adult dose: For most systemic fungal infections, the recommended dose is 100 mg to 200 mg once or twice daily depending on the infection and severity. For onychomycosis, a pulse regimen is used: 200 mg (two 100 mg capsules) twice daily for 1 week, followed by 3 weeks off; this cycle is repeated for 2 months for fingernail infections and 3 months for toenail infections. Capsules must be taken with a full meal to enhance absorption, and they should be swallowed whole. In patients with reduced gastric acid (e.g., those taking proton pump inhibitors or H2 blockers), absorption is impaired; an acidic beverage such as a cola may help. The 100 mg capsule is the standard formulation. The maximum recommended dose is 400 mg per day, except in life-threatening infections where up to 600 mg per day has been used under specialist supervision. If a dose is missed, it should be taken as soon as remembered, but two doses should not be taken at the same time. No dose adjustment is required in renal impairment, but caution is advised; in hepatic impairment, dose reduction may be necessary.
Dosage form: Oral capsules: 100 mg (blue and pink, size 0, imprinted with "JANSSEN" and "SPORANOX"). Each capsule contains 100 mg of itraconazole in a pellet formulation for optimal absorption. Available in blister packs of 28 capsules.
Onset of action: Steady-state plasma concentrations are achieved after approximately 15 days of continuous dosing. For onychomycosis, visible improvement in nail appearance may not be apparent for several months because the nail must grow out; clinical cure is assessed 9 to 12 months after initiation of therapy. For systemic infections, clinical response may begin within the first 2 weeks of therapy.
Duration of action: The elimination half-life of itraconazole is approximately 21 hours after a single dose and increases to 30 to 40 hours at steady state. The antifungal effect persists after the last dose due to accumulation in tissues, including skin and nails. Pulse therapy for onychomycosis relies on the persistence of drug in the nail matrix for weeks after each pulse.
Alcohol recommendation: Alcohol should be avoided during treatment with Sporanox. Itraconazole is extensively metabolized by the liver and can cause hepatotoxicity, including rare cases of fatal liver failure. Concurrent alcohol consumption may exacerbate hepatic injury and increase the risk of serious liver toxicity. Patients should be counselled to abstain from alcohol during therapy and to report any signs of liver dysfunction, such as fatigue, dark urine, jaundice, or abdominal pain.
Most common side effects: Gastrointestinal disturbances including nausea, vomiting, diarrhea, abdominal pain, and dyspepsia; headache; rash; and elevated hepatic enzymes. Hepatotoxicity is a serious concern; baseline and periodic liver function tests are recommended for patients on prolonged therapy. Itraconazole has a negative inotropic effect and is contraindicated in patients with a history of congestive heart failure; it should not be used in patients with ventricular dysfunction. Itraconazole is a potent inhibitor of CYP3A4 and a substrate of P-glycoprotein; serious drug interactions can occur with many medications, including midazolam, triazolam, ergot alkaloids, simvastatin, lovastatin, quinidine, and certain calcium channel blockers. Concomitant use with these agents may lead to life-threatening arrhythmias or rhabdomyolysis. Itraconazole can also prolong the QT interval; caution is required in patients with a history of QT prolongation or those taking other QT-prolonging drugs. Peripheral neuropathy has been reported with prolonged therapy; treatment should be discontinued if it occurs. Sporanox capsules should not be used interchangeably with the oral solution, as their indications and bioavailability differ. In Canada, Sporanox is available only by prescription and must be prescribed and monitored by a healthcare professional experienced in fungal infections.
Would you like to try Sporanox (Itraconazole) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
